Skip to main navigation Skip to search Skip to main content

Epidemiology, treatment and costs of depression in adults with Type 2 diabetes

  • Medical University of South Carolina

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations

Abstract

Worldwide, diabetes and depression are highly prevalent conditions that are independently-associated with increased healthcare costs, disability, lost productivity, and premature mortality. Approximately 10% of individuals with diabetes have major depression and 30% have both major and minor depression. Individuals with diabetes have two-fold increased odds of having depression compared with individuals without diabetes. Although, there are effective treatments for depression, studies have shown that only 50% of adults with depression are recognized in primary care and that treatment for depression is less than ideal in this setting. The epidemiology, treatment and costs of depression in adults with Type 2 diabetes are reviewed and an expert opinion on the best treatments for depression, and future clinical and research directions in this field of research are offered.

Original languageEnglish
Pages (from-to)251-262
Number of pages12
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume3
Issue number3
DOIs
StatePublished - Jun 2003

Keywords

  • Comorbidity
  • Costs and cost analysis
  • Delivery of healthcare
  • Depression
  • Depressive disorder
  • Diabetes mellitus noninsulin dependent
  • Economics
  • Epidemiology
  • Therapeutics

Fingerprint

Dive into the research topics of 'Epidemiology, treatment and costs of depression in adults with Type 2 diabetes'. Together they form a unique fingerprint.

Cite this